rs2072711

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000631.5(NCF4):​c.627+88A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.835 in 1,152,614 control chromosomes in the GnomAD database, including 402,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.86 ( 56218 hom., cov: 27)
Exomes 𝑓: 0.83 ( 346151 hom. )

Consequence

NCF4
NM_000631.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.829

Publications

19 publications found
Variant links:
Genes affected
NCF4 (HGNC:7662): (neutrophil cytosolic factor 4) The protein encoded by this gene is a cytosolic regulatory component of the superoxide-producing phagocyte NADPH-oxidase, a multicomponent enzyme system important for host defense. This protein is preferentially expressed in cells of myeloid lineage. It interacts primarily with neutrophil cytosolic factor 2 (NCF2/p67-phox) to form a complex with neutrophil cytosolic factor 1 (NCF1/p47-phox), which further interacts with the small G protein RAC1 and translocates to the membrane upon cell stimulation. This complex then activates flavocytochrome b, the membrane-integrated catalytic core of the enzyme system. The PX domain of this protein can bind phospholipid products of the PI(3) kinase, which suggests its role in PI(3) kinase-mediated signaling events. The phosphorylation of this protein was found to negatively regulate the enzyme activity. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
NCF4 Gene-Disease associations (from GenCC):
  • granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • chronic granulomatous disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-36872513-A-G is Benign according to our data. Variant chr22-36872513-A-G is described in ClinVar as Benign. ClinVar VariationId is 1289546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.937 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCF4NM_000631.5 linkc.627+88A>G intron_variant Intron 7 of 9 ENST00000248899.11 NP_000622.2 Q15080-1
NCF4NM_013416.4 linkc.627+88A>G intron_variant Intron 7 of 8 NP_038202.2 Q15080-3
NCF4XM_047441384.1 linkc.801+88A>G intron_variant Intron 8 of 10 XP_047297340.1
NCF4XM_047441385.1 linkc.771+88A>G intron_variant Intron 8 of 10 XP_047297341.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCF4ENST00000248899.11 linkc.627+88A>G intron_variant Intron 7 of 9 1 NM_000631.5 ENSP00000248899.6 Q15080-1

Frequencies

GnomAD3 genomes
AF:
0.861
AC:
129932
AN:
150942
Hom.:
56151
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.945
Gnomad AMI
AF:
0.765
Gnomad AMR
AF:
0.867
Gnomad ASJ
AF:
0.863
Gnomad EAS
AF:
0.677
Gnomad SAS
AF:
0.798
Gnomad FIN
AF:
0.834
Gnomad MID
AF:
0.823
Gnomad NFE
AF:
0.832
Gnomad OTH
AF:
0.860
GnomAD4 exome
AF:
0.831
AC:
831906
AN:
1001554
Hom.:
346151
AF XY:
0.830
AC XY:
426989
AN XY:
514530
show subpopulations
African (AFR)
AF:
0.949
AC:
23581
AN:
24836
American (AMR)
AF:
0.862
AC:
33863
AN:
39294
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
19647
AN:
22932
East Asian (EAS)
AF:
0.711
AC:
26307
AN:
37002
South Asian (SAS)
AF:
0.818
AC:
61388
AN:
75062
European-Finnish (FIN)
AF:
0.845
AC:
40822
AN:
48314
Middle Eastern (MID)
AF:
0.831
AC:
3753
AN:
4518
European-Non Finnish (NFE)
AF:
0.830
AC:
584231
AN:
704108
Other (OTH)
AF:
0.842
AC:
38314
AN:
45488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6873
13745
20618
27490
34363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10756
21512
32268
43024
53780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.861
AC:
130057
AN:
151060
Hom.:
56218
Cov.:
27
AF XY:
0.860
AC XY:
63414
AN XY:
73766
show subpopulations
African (AFR)
AF:
0.945
AC:
38959
AN:
41230
American (AMR)
AF:
0.867
AC:
13177
AN:
15196
Ashkenazi Jewish (ASJ)
AF:
0.863
AC:
2989
AN:
3464
East Asian (EAS)
AF:
0.677
AC:
3435
AN:
5074
South Asian (SAS)
AF:
0.798
AC:
3801
AN:
4764
European-Finnish (FIN)
AF:
0.834
AC:
8703
AN:
10430
Middle Eastern (MID)
AF:
0.834
AC:
242
AN:
290
European-Non Finnish (NFE)
AF:
0.832
AC:
56257
AN:
67614
Other (OTH)
AF:
0.860
AC:
1810
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
855
1710
2565
3420
4275
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.842
Hom.:
178198
Bravo
AF:
0.866
Asia WGS
AF:
0.798
AC:
2772
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 63% of patients studied by a panel of primary immunodeficiencies. Number of patients: 60. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.53
DANN
Benign
0.57
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072711; hg19: chr22-37268555; API